CHARLOTTE, N.C. (AP) – An Irish pharmaceutical company is closing its Charlotte manufacturing plant, a move that will cost 390 local jobs.
The Charlotte Observer reports (http://bit.ly/1QY4G09) that Qualitest Pharmaceuticals, a subsidiary of Endo International, announced last week that it is closing the facility in Charlotte and reducing its Huntsville, Alabama, workforce to cut costs. The company currently operates an 88,000-square-foot manufacturing plant in North Charlotte that produces tablets and capsules of generic medicines.
Endo Senior Director of Corporate Affairs Heather Zoumas Lubeski says the company will provide resources to “help employees manage through this transition.”
The restructuring and closure of the Charlotte plant is expected to save the company $60 million in 2017.
Information from: The Charlotte Observer, http://www.charlotteobserver.com